Olema Pharmaceuticals, Inc.
OLMA
$4.89
-$0.005-0.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.68% | -0.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.27% | 12.20% | |||
| Operating Income | 2.27% | -12.20% | |||
| Income Before Tax | 2.86% | -13.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.86% | -13.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.86% | -13.74% | |||
| EBIT | 2.27% | -12.20% | |||
| EBITDA | 2.33% | -12.23% | |||
| EPS Basic | 15.45% | -11.78% | |||
| Normalized Basic EPS | 15.46% | -11.80% | |||
| EPS Diluted | 15.45% | -11.78% | |||
| Normalized Diluted EPS | 15.46% | -11.80% | |||
| Average Basic Shares Outstanding | 14.90% | 1.74% | |||
| Average Diluted Shares Outstanding | 14.90% | 1.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||